Skip to main content

UBS Group AG

Position in NRSN — NeuroSense Therapeutics Ltd.

CIK 1610520 ZURICH, V8

Position in NRSN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$37,067
+$13,329 QoQ
Shares Held
49,096
+59.0% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRSN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NRSN ranks #412 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NRSN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $37,067 49,096
2025-12-31 $23,738 30,871
2025-09-30 $18,323 14,659
2025-06-30 $3,044 1,611
2025-03-31 $2,115 2,275
2024-03-31 $21,708 11,928
2023-12-31 $4,314 5,496
2023-09-30 $6,862 9,665
2023-03-31 $8,190 4,762
2022-12-31 $4,959 4,065
2022-09-30 $3,270 1,827
2022-06-30 $45,386 13,428
2022-03-31 $7,479 1,884
2021-12-31 $19,724 8,018